The • Both internal and external carotid artery phasic blood flow and arterial pressure were measured in five patients during a control period and after the intra-arterial injection of 13.8 fig of histamine phosphate into each vessel. In the internal carotid artery, flow for the group increased almost immediately and reached a maximum value of 59% greater than control in ten seconds. The total duration of the response in both pressure and flow lasted approximately one minute. The injection of histamine into the external carotid artery elicited a much more marked response, having a maximum increase in flow of 294% for the group with a total duration of the response lasting two and one-half to three minutes. These data define the magnitude and time course of the action of histamine phosphate on the intracranial and extracranial circulation in man.
Introduction
• Although histamine has been shown to dilate the vessels of the cerebral circulation, the magnitude and duration of this action have not been defined previously in man. 1 In the studies reported herein, phasic blood flow and pressure were measured in the internal carotid artery following the intra-arterial injection of a small dose of histamine. For comparison, the same dose of histamine was infused into the external carotid artery and similar data recorded.
Methods
Five male patients were studied who had been hospitalized on the Neurosurgical Service of the Durham Veterans Administration Hospital, Durham, North Carolina. In each patient subtotal resection of a supratentorial malignant brain tumor had been carried out from 10 to 20 days previously. The data described in this report were obtained during exposure of the carotid vessels so that an antitumor agent (S-112, a chlorethylthioacetamide, 8 /xg/kg) could be infused directly into the internal carotid artery. This drug was given immediately after the completion of the studies described below. The informed consent of each patient was obtained. At the time of study, the patients were alert and showed no major neurological deficits and the cerebrospinal fluid pressure was less than 200 mm H 2 O.
Before the surgical procedure the patients were premedicated with 50 mg of meperidine and 25 mg of promethazine. Local anesthesia was accomplished with injections of lidocaine. The common carotid artery and proximal portions of both the internal and external carotid arteries were exposed, and the small arterial branches in this area were ligated. The probe of a Statham Model K-2000 electromagnetic flowmeter (EMF) was placed around the common carotid artery proximal to its bifurcation. The probe size was selected so that the vessel was not constricted more than was necessary to obtain an adequate flow signal. Since the EMF probe was on the common carotid artery, flow in either the internal or external carotid artery could be measured by occluding the other vessel with a nontraumatic arterial clamp. The internal carotid artery was never occluded longer than three minutes and during this time the neurological status of the patient was tested frequently. A short polyvinyl catheter was inserted into the superior thyroid artery and the tip advanced to the common carotid artery. This catheter was connected to a Statham P23Db strain gauge and used for recording arterial pressure. Histamine phosphate (13.8 /tig in 1 cm 3 of normal saline) was infused as a bolus through a 23-gauge needle into either the internal or external carotid artery distal to the carotid sinus.
Both mean and pulsatile blood flows and pressures were recorded continuously during the control period and following administration of histamine for a threeminute period. The zero-flow reference was obtained by temporarily occluding the vessel distal to the probe. The 
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Control data are listed under panel A; B and C are at five and ten seconds following injection, respectively. Only flow data are given in these two panels since no change occurred in the other measured parameters at these times. In panel D data obtained concomitant with the maximum decrease in mean arterial pressure (20 to 30 seconds) are listed. In panel E data obtained at one minute are given. The P values given below the mean data rows compare the control values with that particular parameter. N.S. signifies P > 0.05. The P value listed on the bottom row compares the percent changes in that particular parameter between the internal •and external carotid artery. For example, the flow response at ten seconds is significantly greater in the external carotid artery.
EMF was calibrated by passing known quantities of physiological saline through the probes in a given period of time. The instrument was found to be linear ± 2% through the range of flows encountered and the calibration factor remained within an SD ± 5 % . Arterial blood samples were obtained for measurement of P C02 using an Instrumentation Laboratories Model 113 gas analyzer. All recording of data was carried out on a Sanborn Model 850 direct-writing oscillograph at paper speeds of either 2.5 or 5 mm/sec.
Control pressure-flow data were calculated as the average values of five consecutive heart beats just before the administration of histamine. After the intra-arterial injection of the drug, pressure-flow data were measured at 5, 10, 20 to 30 seconds, and one minute. Data chosen at 20 to 30 seconds represent the maximum decrease in arterial pressure. Both the mean flow and arterial pressure were read directly from the oscillographical recordings. The peak and nadir values of the flow pulse as well as the systolic and diastolic blood pressures were measured. The vascular resistances of both the internal and external carotid arteries were calculated as the mean arterial pressure divided by mean blood flow in that vessel. Data were evaluated by using standard statistical techniques.
Results
The pertinent hemodynamic data are summarized in table 1 and a representative recording is illustrated in figure 1 . The injection of histamine into the internal carotid artery was followed in one to two seconds by a rapid increase in flow which reached a Stroke, Vol. 4, January-February 1973 maximum increase of 59% for the group in ten seconds. At this time, there was no detectable change in either heart rate or blood pressure. Between 20 and 30 seconds after injection the maximum decrease in blood pressure of 23 % for the group was noted and was accompanied by a significant increase in heart rate. At this time the flow had decreased somewhat but was still 11% higher than during the control. Thus, the vascular resistance was decreased 32% from control values. At one minute all the hemodynamic parameters had returned to control levels except for the heart rate which continued to be 30% higher than the control values for the group. The heart rate returned to within the control values within two and one-half minutes after the injection.
The hemodynamic response to the injection of histamine into the external carotid artery was more marked and of a longer duration. At ten seconds following the injection, the flow increased to 241% for the group without changes in arterial pressure or heart rate. The maximum decrease in mean arterial pressure of 10% occurred between 20 and 30 seconds following the injection and was accompanied by a 294% increase in flow and a 78% decrease in vascular resistance. At one minute the blood pressure had returned to control values but the mean blood flow was 132% greater than the control for the group. The heart rate was 27% higher than control at this time. The flow and heart rate returned to control values at two and one-half to three minutes following the injection in all patients. During the control period the arterial P COo for the group was 42.8 mm Hg ± 1.1 (SEM). The injection of histamine in either vascular bed did not elicit symptoms in any of the patients except for a feeling of fullness and warmth in the face following the injection into the external carotid artery. No significant changes in arterial P C o 2 were observed. 
Discussion
Intravenous infusion of histamine phosphate has been generally accepted to produce vasodilatation in most vascular beds including the cerebral. 1 Due to the systemic hemodynamic effects, it is difficult to define the effects on one vascular bed of a drug following intravenous infusion. Thus, infusion of the drug directly into the arterial circulation allows the more quantitative evaluation. The injection of a small dose of histamine into the internal carotid artery in our patients produced an immediate vasodilatation which reached its maximum in ten seconds and was unaccompanied at that time by any changes in either heart rate or blood pressure, indicating a lack of systemic effects. The response, however, was quite transient, lasting less than a minute. These data are quite similar to those reported by Dumke and Schmidt, 2 who used a bubble flowmeter to measure cerebral flow in the monkey. These investigators noted approximately a 40% increase in cerebral flow following a minute dose of histamine injected into the carotid artery. It is quite apparent from our data that a much more marked response in both magnitude and duration was elicited from injection of histamine into the external carotid artery. It is of interest that the mean arterial pressure decreased significantly less following injection into the external carotid artery. This may indicate that more of the drug was removed by the external carotid artery vascular bed than by the intracranial bed, and thus less was available to produce the systemic hypotensive effects. The less marked vasodilator action of histamine in the cerebral circulation when compared to the extracerebral vascular bed has been noted in previous studies carried out by Schmidt and Hendrix. 3 The lack of symptoms produced in our patients following the injection of histamine is of interest since histamine has been clearly implicated in the production of headache. The probable explanation for this discrepancy lies in the fact that the patients in our study had been premedicated with analgesics. We do not intend to imply from these data that histamine does not cause headache in other circumstances.
